Protein Nanocapsules for Stable Intracellular Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge lies in the low efficiency of intracellular delivery and poor stability of therapeutic proteins due to their poor permeability through cell membranes and susceptibility to proteases, which limits their application in treating diseases such as cancer and protein-deficient conditions.
Innovation Solution
The development of protein nanocapsules with a single-protein core and a thin polymer shell that is covalently anchored, providing enhanced stability and cellular uptake through endocytosis, while maintaining enzymatic activity and resistance to proteases.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If therapeutic proteins are administered directly, then protein therapy can be provided, but intracellular delivery efficiency is low and stability against proteases is poor
Solution Approach 1:
The therapeutic protein is encapsulated within a nanocapsule structure, nesting the protein core inside a protective polymer shell. This nesting approach protects the protein from protease degradation while enabling efficient cellular uptake through endocytosis, resolving the contradiction between stability and delivery efficiency
Solution Approach 2:
A thin polymer shell is formed around the protein core through in-situ polymerization. This flexible shell provides protease resistance while maintaining sufficient permeability for substrate access to the encapsulated protein, achieving both stability and functional activity
2Productivity
If proteins are delivered into cells via receptor-mediated endocytosis, then cellular delivery is achieved, but proteins are entrapped in endosomes and degraded in lysosomes
Solution Approach 1:
The nanocapsule structure changes the physical and chemical parameters of protein delivery, including size (nanoscale), surface charge (positive zeta potential for enhanced endocytosis), and structural integrity. These parameter changes enable efficient cellular uptake while the robust shell prevents lysosomal degradation, resolving the contradiction between delivery efficiency and intracellular stability
3Reliability
If a polymer shell is added to protect proteins, then stability against proteases is improved, but device complexity increases
Solution Approach 1:
The nanocapsule structure is formed through self-service mechanisms where the polymer shell is synthesized in-situ around the protein core using the protein's own surface groups as initiation sites. This self-organizing approach simplifies the overall process while providing robust protease resistance, balancing stability improvement with structural simplicity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The nanocapsules achieve high intracellular delivery efficiency and prolonged protein activity, reducing the required protein dosage and improving therapeutic outcomes by protecting the protein core from degradation and aggregation.
Implementation Method 1
the single-protein core is copolymerized with at least one monomer to form the nanocapsule
Implementation Method 2
providing enhanced stability and cellular uptake through endocytosis
Data Source
AI summary
A protein nanocapsule having a single-protein core and a thin polymer shell anchored covalently to the protein core.